Glucagon-like peptide-1 (GLP-1) drugs have emerged as a revolutionary class of medications in the treatment of type 2 diabetes and obesity. These drugs, known as GLP-1 receptor agonists, mimic the natural hormone GLP-1 that the body produces in response to food intake. The hormone plays a key role in regulating blood sugar levels, promoting satiety, and slowing gastric emptying. Originally...